We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NAPRO'S PACLITAXEL PATENTS VALID, COURT FINDS
NAPRO'S PACLITAXEL PATENTS VALID, COURT FINDS
January 13, 2004
Mylan said it would appeal a recent federal court ruling that rejected the firm’s claims that NaPro BioTherapeutics obtained its formulation patents for a generic paclitaxel product through fraud and inequitable conduct on the U.S. Patent and Trademark Office.